The ability of GDNF to promote the survival of midbrain dopaminergic neurons made it a prime candidate for therapeutic approaches to Parkinson’s disease (PD), where a large fraction of these neurons in the substantia nigra (SN) are lost to degeneration. Here, GDNF is linked to Parkinson disease.